Speech-Language Pathologists in Paola, KS Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Mrs. Angela Lukert, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 908 N Pearl St, Paola, KS 66071 Phone: 913-294-4308

Lisa Boehnlein Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 S Hospital Dr, Suite 400, Paola, KS 66071 Phone: 913-294-4343

Jessie Caceres, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 608 E Shawnee St, Paola, KS 66071 Phone: 650-863-8632

Mrs. Fe Lizette Vergara Douglas, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Lakemary Dr, Paola, KS 66071 Phone: 913-557-4000

Mrs. Maria Elaine Heid, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2103 Lakeview Drive, Paola, KS 66071 Phone: 913-557-3974

Jennie Jennings Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 908 N Pearl St, Paola, KS 66071 Phone: 913-294-4308

Jodi L Maynard, MA.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1401 E 303rd St, Paola, KS 66071 Phone: 913-294-8040    Fax: 913-294-8041

Rebecca S. Ryckert, M.S./CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14713 W 311th St, Paola, KS 66071 Phone: 509-750-7401

News Archive

BSR report outlines plans to help patients make informed choices about their treatment

A lack of national data and indicators in the UK makes it difficult for rheumatologists to demonstrate effective care for patients with inflammatory arthritis. This also leaves patients without the information they need to take control of their care.

FDA Advisory Committee recommends approval of dabigatran etexilate for stroke prevention in AFib patients

The U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee today voted 9 to 0 in favor of approving dabigatran etexilate for stroke prevention in patients with atrial fibrillation (AFib). An estimated 2.3 million Americans have AFib and the prevalence is expected to increase 2.5 fold to 5.6 million by 2050, reflecting the growing population of elderly individuals.

Alnylam, Mount Sinai scientists discover svRNAs that play a critical role in influenza A virus replication

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by Alnylam scientists and collaborators from Mount Sinai School of Medicine. In the new study, Alnylam and Mount Sinai scientists discovered a novel class of virus-produced small non-coding RNAs, called small viral RNAs (svRNAs), which play a critical role in the replication of influenza A virus.

FMCNA ships dialysis machines and supplies for Haiti relief efforts

Fresenius Medical Care North America (FMCNA), the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, is donating and delivering dialysis supplies to Haitians, at a time when relief supplies continue to be slow to reach those in need following a devastating earthquake and aftershock.

Read more Medical News

› Verified 1 days ago